Fleischer, Lisa, Hanna Kirchhoff, Caroline Schoenherr, Olaf Heidenreich, Michaela Scherr, and Matthias Eder. 2020. “Combining Inotuzumab Ozogamicin With the p38 Inhibitor BIRB 796 and Venetoclax Exerts Synergistic Cytotoxicity in B-Cell Precursor Acute Lymphoblastic Leukemia Including Very High Risk t(17;19) Acute Lymphoblastic Leukemia”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.300519.